Cardiac prophylactic treatment began before age 14 for 27.7% of the cohort. Compared with patients not treated prophylactically, treatment was associated with a 54% reduction in death.

Lexeo Therapeutics laid off 15% of its staff last month as part of a wider plan to siphon $20 million from its pipeline to fund the gene therapy biotech’s lead cardiac programs.. One of these ...

Pfizer reported $5.4 billion in sales for tafamidis in 2024, up more than 60% year on year. Matt Outten, chief commercial officer at BridgeBio, said at a Leerink investor event in March that around 24 ...

Cardiac muscle tissue exists only in the heart. Here, it is responsible for keeping the heart pumping and relaxing normally. Conditions that affect this tissue can affect the heart’s ability to ...

Researchers have identified a crucial growth factor, BMP7, capable of stimulating cardiac muscle cell proliferation and regeneration, potentially offering new treatments for heart injuries.

Researchers at the University of Toronto and its partner hospitals have led the development of a heart-on-a-chip device to study the effects of a genetic mutation that causes dilated cardiomyopathy, a ...

Mount Sinai’s Cardiovascular Research Institute is sending bioengineered human heart muscle cells and micro-tissues into space for the first time on NASA’s 29 th SpaceX commercial resupply ...

Hegedus says each muscle type is distinguished by different functions. "The muscles you can see that give our body its shape and help us move are skeletal muscles; the ones that mostly function ...

Damage to the heart muscle, e.g. due to a heart attack, therefore usually leads to a permanent loss of function in adults. Scientists from the Max Planck Institute for Heart and Lung Research have now ...

The muscle will respond by rapidly contracting, or rippling, for about 5 to 20 seconds. External pressure, like a bump to the muscle, can also cause the muscle to "bunch up, or muscle mound, or ...